SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.30), $0.07 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $21.62 million.

Outlook:-

Full year revenue between $94 million and $96 million vs consensus $93.38 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.